Real-world treatment patterns, adverse events and clinical outcomes in patients with chronic lymphocytic leukaemia treated with ibrutinib in the United Kingdom

被引：0
作者：
Xie, J. [1 ]
Yong, A. S. M. [2 ]
Waweru, C. [1 ]
Sorof, T. -A. [3 ]
Goyal, R. K. [4 ]
Davis, K. L. [4 ]
Hillmen, P. [5 ]
机构：
[1] AstraZeneca LP, Gaithersburg, MD USA
[2] AstraZeneca, Luton, Beds, England
[3] Acerta Pharma, San Francisco, CA USA
[4] RTI Hlth Solut, Res Triangle Pk, NC USA
[5] St James Univ Hosp, Leeds, W Yorkshire, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH2020-EP
引用
收藏
页码：221 / 221
页数：1
相关论文
共 50 条
  • [21] Real-world Clinical Outcomes of First-Line Ibrutinib or Chemoimmunotherapy in Patients with Chronic Lymphocytic Leukemia by Risk Status
    Qing Huang
    Kathleen L. Deering
    Qing Harshaw
    Lori A. Leslie
    Advances in Therapy, 2022, 39 : 3292 - 3307
  • [22] INFECTIOUS COMPLICATIONS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA TREATED WITH IBRUTINIB
    Wasik-Szczepanek, E.
    Szymczyk, A.
    Czabak, O.
    Cioch, M.
    Wach, M.
    Podhorecka, M.
    Sokolowska, B.
    Pasiarski, M.
    Kozinska, J.
    Hus, I.
    Szczepanek, D.
    Kotwica, K.
    Szczepanek, A.
    Hus, M.
    HAEMATOLOGICA, 2017, 102 : 722 - 722
  • [23] Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)
    Spacek, Martin
    Smolej, Lukas
    Simkovic, Martin
    Nekvindova, Lucie
    Kristkova, Zlatuse
    Brychtova, Yvona
    Panovska, Anna
    Maslejova, Stanislava
    Bezdekova, Lucie
    Ecsiova, Dominika
    Vodarek, Pavel
    Zuchnicka, Jana
    Mihalyova, Jana
    Urbanova, Renata
    Turcsanyi, Peter
    Lysak, Daniel
    Novak, Jan
    Brejcha, Martin
    Likarova, Tereza
    Vodicka, Prokop
    Baranova, Jana
    Trneny, Marek
    Doubek, Michael
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (01) : 40 - 47
  • [24] Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis
    Mato, Anthony R.
    Nabhan, Chadhi
    Thompson, Meghan C.
    Lamanna, Nicole
    Brander, Danielle M.
    Hill, Brian
    Howlett, Christina
    Skarbnik, Alan
    Cheson, Bruce D.
    Zent, Clive
    Pu, Jeffrey
    Kiselev, Pavel
    Goy, Andre
    Claxton, David
    Isaac, Krista
    Kennard, Kaitlin H.
    Timlin, Colleen
    Landsburg, Daniel
    Winter, Allison
    Nasta, Sunita D.
    Bachow, Spencer H.
    Schuster, Stephen J.
    Dorsey, Colleen
    Svoboda, Jakub
    Barr, Paul
    Ujjani, Chaitra S.
    HAEMATOLOGICA, 2018, 103 (05) : 874 - 879
  • [25] Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia
    Roeker, Lindsey E.
    DerSarkissian, Maral
    Ryan, Kellie
    Chen, Yan
    Duh, Mei Sheng
    Wahlstrom, Svea K.
    Hakre, Shweta
    Yu, Louise
    Guo, Helen
    Mato, Anthony R.
    BLOOD ADVANCES, 2023, 7 (16) : 4291 - 4301
  • [26] Real World Treatment Patterns, Adverse Events and Healthcare Resource Utilization and Costs Among Chronic Lymphocytic Leukemia (CLL) Patients in the United States
    Kabadi, Shaum
    Le, Lisa
    Byfield, Stacey Dacosta
    Olufade, Temitope O.
    BLOOD, 2018, 132
  • [27] Real-world costs of chronic lymphocytic leukaemia in the Netherlands
    Holtzer-Goor, K. M.
    Bouwmans-Frijters, C. A. M.
    Schaafsma, M. R.
    de Weerdtc, O.
    Joosten, P.
    Posthuma, E. F. M.
    Wittebol, S.
    Huijgens, P. C.
    Matthssen, E. J. M.
    Vreugdenhil, G.
    Visser, H.
    Peters, W. G.
    Erjavec, Z.
    Wijermans, P. W.
    Daenen, S. M. G. J.
    van der Hem, K. G.
    van Oers, M. H. J.
    Uyl-de Groot, C. A.
    LEUKEMIA RESEARCH, 2014, 38 (01) : 84 - 90
  • [28] Real-World Treatment Patterns and Outcomes after Ibrutinib Discontinuation Among Elderly Medicare Beneficiaries with Chronic Lymphocytic Leukemia: An Observational Study
    Huntington, Scott F.
    De Nigris, Enrico
    Puckett, Justin
    Kamal-Bahl, Sachin
    Farooqui, Mohammed Z. H.
    Ryland, Katherine Elizabeth
    Sarpong, Eric
    Yang, Xiaoqin
    Doshi, Jalpa
    BLOOD, 2022, 140 : 7939 - 7940
  • [29] Real-world clinical outcomes and treatment patterns in patients with MDD treated with vortioxetine: a retrospective study
    Brandon T. McDaniel
    Victor Cornet
    Jeanne Carroll
    Lambros Chrones
    Joseph Chudzik
    Jeanette Cochran
    Shion Guha
    Debra F. Lawrence
    Maggie McCue
    Sara Sarkey
    Betty Lorenz
    Jay Fawver
    BMC Psychiatry, 23
  • [30] Real-World Dosing Patterns and Outcomes Among Patients With Chronic Lymphocytic Leukemia With or Without Dose Adjustment of First-Line Ibrutinib
    Rogers, Kerry
    Lu, Xiaoxiao
    Emond, Bruno
    Ding, Zhijie
    Lefebvre, Patrick
    Lafeuille, Marie-Helene
    Mavani, Heena
    Qureshi, Zaina
    Ghosh, Nilanjan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S330 - S330
12345